Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Exploring new opportunities within the fast-growing market of microfluidics
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
This facility marks a significant milestone in transforming the global food industr
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Harnessing advanced data analysis for early detection, prevention and better outcomes
Subscribe To Our Newsletter & Stay Updated